Anti-lung cancer properties of cyanobacterial bioactive compounds

Area of Science:

• Marine Biology
• Pharmacology
• Oncology

Background:

• Lung cancer remains a leading cause of cancer deaths globally, with limited therapeutic advancements.
• Current treatments like immunotherapy and chemotherapy offer modest improvements in patient survival.
• Novel therapeutic strategies are crucial for enhancing lung cancer treatment outcomes.

Purpose of the Study:

• To review promising cyanobacteria-derived compounds with anti-cancer properties.
• To highlight the potential of these compounds as therapeutic agents against lung cancer.
• To explore new sources for effective lung cancer treatments.

Main Methods:

• Literature review of in-vitro and in-vivo studies.
• Analysis of bioactive compounds synthesized by cyanobacteria.
• Focus on anti-lung cancer properties of identified compounds.

Main Results:

• Cyanobacteria produce diverse bioactive compounds with significant anti-cancer potential.
• These compounds have demonstrated efficacy against various cancer cell lines and in animal models.
• Several cyanobacteria-derived agents show promise for anti-lung cancer applications.

Conclusions:

• Cyanobacteria represent a valuable and largely untapped resource for discovering novel anti-cancer drugs.
• Bioactive compounds from cyanobacteria warrant further investigation for their therapeutic potential in lung cancer.
• Exploring natural sources like cyanobacteria is key to developing next-generation lung cancer therapies.